|
Market Closed -
Xetra
18:35:45 21/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 52.45 EUR | +3.92% |
|
+3.92% | - |
| 08-13 | Zealand Pharma sells rusfertide rights for $100m | FW |
| 08-13 | Zealand Pharma to Sell Rusfertide-linked Economics to Royalty Pharma for $100 Million | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RPRX Stock
- RPD Stock
- Consensus Royalty Pharma plc
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
